FDA Inspection 596000 — Lymol Medical Corporation

Lymol Medical Corporation — FEI 1221129

The FDA completed an inspection of Lymol Medical Corporation on July 9, 2009 in Woburn, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 9, 2009
Fiscal Year
2009
Product Type
Devices
Project Area
Compliance: Devices
Location
Woburn, MA (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
200921 CFR 211.188Prepared for each batch, include complete information